Medication info

Intro Minoxidil Tablet

Prescription medicationTabletOralApproval withdrawn
Ingredient · strength
Minoxidil›5mg
Manufacturer / importer
Intro Biopharma Co., Ltd.
Appearance
White round tablet
Packaging
30 tablets/bottle, 300 tablets/bottle, 500 tablets/bottle, 100 tablets/bottle
Approval status
Approval withdrawn

MFDS item code 202103847 · Notified 2021.05.14

This product's status changed to Approval withdrawn on 2024.10.11. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of symptomatic hypertension with target-organ damage and resistant hypertension
Who takes it
Adults · Children
Adult dose
Adults (12 years and older): The initial oral dose of minoxidil is 5㎎ once daily, and the maintenance dose is 10-40㎎ per day in 1-several divided doses. A maximum of 100㎎ per day may be administered. Frequency of administration: During treatment with this drug, the magnitude of daily fluctuations in arterial blood pressure is proportional to the amount of blood pressure reduction. If the reduction in supine diastolic blood pressure is less than 30mmHg, once-daily administration is sufficient; if the reduction in supine diastolic blood pressure is 30mmHg or more, administer the dose in 2 divided doses daily. Dose adjustment: The dose should be determined carefully according to the patient's response. When adjusting the dose, allow an interval of at least 3 days as a sufficient response to the dose generally takes 3 days or longer to appear. If more rapid treatment of hypertension is required, the dose may be adjusted every 6 hours while carefully monitoring the patient. Concomitant administration Diuretics: This drug is administered with a diuretic in patients whose salt and water balance depends on renal function. It has been used concomitantly with the following diuretics. ① Hydrochlorothiazide (50㎎ per dose twice daily) or another thiazide diuretic (equivalent effective dose) ② Chlorthalidone (50-100㎎ per dose once daily) ③ Furosemide (40㎎ per dose twice daily) If excessive salt and water retention results in a weight gain of approximately 1.8㎏ or more, the diuretic should be changed to furosemide; if the patient is already receiving furosemide, increase the dose as needed. β-blockers or other sympatholytic agents: During treatment with this drug, administer a β-blocker equivalent to propranolol 80-160㎎ per day in divided doses. If a β-blocker is contraindicated, methyldopa (250-750㎎ per dose twice daily) may be given instead. Since methyldopa takes time to exert its effect, administer it at least 24 hours before starting this drug. Sympatholytic agents may not completely block the increase in heart rate caused by this drug, but can generally prevent tachycardia. Patients receiving a β-blocker before starting treatment with this drug typically have bradycardia; however, the heart rate is expected to increase to normal when this drug is administered. Concomitant administration of this drug with a β-blocker or other sympatholytic agent may result in little change in heart rate because their opposing effects on the heart counterbalance each other. Adjust the dose appropriately according to age and symptoms.
Child dose
Children (12 years and younger): The initial dose is 0.2㎎/㎏ once daily. The dose may be increased by 50-100% until blood pressure is optimally controlled. The maintenance dose is 0.25㎎-1.0㎎/㎏ per day. A maximum of 50㎎ per day may be administered.

Ingredients

Manufacturer
Intro Biopharma Co., Ltd.

Efficacy & effects

Treatment of symptomatic hypertension with target-organ damage and resistant hypertension

  • Hypertension
  • resistant hypertension
View approved original text

This medication is used to treat symptomatic hypertension or hypertension caused by specific organ damage, as well as resistant hypertension that does not respond to diuretics and two other antihypertensives.

How to take

Adult dose

Adults (12 years and older): The initial oral dose of minoxidil is 5㎎ once daily, and the maintenance dose is 10-40㎎ per day in 1-several divided doses. A maximum of 100㎎ per day may be administered. Frequency of administration: During treatment with this drug, the magnitude of daily fluctuations in arterial blood pressure is proportional to the amount of blood pressure reduction. If the reduction in supine diastolic blood pressure is less than 30mmHg, once-daily administration is sufficient; if the reduction in supine diastolic blood pressure is 30mmHg or more, administer the dose in 2 divided doses daily. Dose adjustment: The dose should be determined carefully according to the patient's response. When adjusting the dose, allow an interval of at least 3 days as a sufficient response to the dose generally takes 3 days or longer to appear. If more rapid treatment of hypertension is required, the dose may be adjusted every 6 hours while carefully monitoring the patient. Concomitant administration Diuretics: This drug is administered with a diuretic in patients whose salt and water balance depends on renal function. It has been used concomitantly with the following diuretics. ① Hydrochlorothiazide (50㎎ per dose twice daily) or another thiazide diuretic (equivalent effective dose) ② Chlorthalidone (50-100㎎ per dose once daily) ③ Furosemide (40㎎ per dose twice daily) If excessive salt and water retention results in a weight gain of approximately 1.8㎏ or more, the diuretic should be changed to furosemide; if the patient is already receiving furosemide, increase the dose as needed. β-blockers or other sympatholytic agents: During treatment with this drug, administer a β-blocker equivalent to propranolol 80-160㎎ per day in divided doses. If a β-blocker is contraindicated, methyldopa (250-750㎎ per dose twice daily) may be given instead. Since methyldopa takes time to exert its effect, administer it at least 24 hours before starting this drug. Sympatholytic agents may not completely block the increase in heart rate caused by this drug, but can generally prevent tachycardia. Patients receiving a β-blocker before starting treatment with this drug typically have bradycardia; however, the heart rate is expected to increase to normal when this drug is administered. Concomitant administration of this drug with a β-blocker or other sympatholytic agent may result in little change in heart rate because their opposing effects on the heart counterbalance each other. Adjust the dose appropriately according to age and symptoms.

Child dose

Children (12 years and younger): The initial dose is 0.2㎎/㎏ once daily. The dose may be increased by 50-100% until blood pressure is optimally controlled. The maintenance dose is 0.25㎎-1.0㎎/㎏ per day. A maximum of 50㎎ per day may be administered.

Precautions

This medication should not be used in patients with certain conditions. For example, it should not be given to patients with pheochromocytoma, a rare tumor, as it may lower blood pressure while increasing the secretion of substances from the tumor. It should also be avoided in patients with pulmonary hypertension due to mitral stenosis, those who have had an acute myocardial infarction, and those who have had allergic reactions to this drug. Caution should be taken in patients with chronic congestive heart failure, severely reduced kidney function, and angina. These patients require closer monitoring of the drug's effects. This medication may commonly cause abnormal hair growth as a side effect. This phenomenon usually starts within 3 to 6 weeks, with hair increasing on the face and body. If the medication is discontinued, new hair growth will stop, but it may take several months to return to baseline. Special care should be given to inform children and women about this side effect in advance. Skin rashes or allergic reactions may also occur, and blood tests may show a decrease in platelet or white blood cell count. Changes may occur in cardiac electrical signals, but most will resolve with continued treatment and will not cause significant cardiac issues. Rarely, pericardial effusion may occur, particularly in patients with poor kidney function. In such cases, additional testing is needed, and if symptoms are severe, discontinuation of the medication may be considered. This medication is typically used alongside diuretics to prevent fluid retention and congestive heart failure. Weight and fluid status should be monitored regularly, and diuretics adjusted as necessary. Because of its vasodilatory effect, it may cause increased heart rate or symptoms of angina, which should be controlled with other medications. Patients with kidney failure or those on dialysis may require a dose reduction, and treatments for myocardial infarction should only be given after the condition stabilizes. Regular examinations such as urinalysis, kidney function tests, ECG, chest X-ray, and echocardiography are required in the early stages of treatment. This medication may interact with other drugs; therefore, caution is advised when used in combination with guanethidine, certain antidepressants, antipsychotics, corticosteroids, and anti-inflammatory pain relievers. The risk of side effects such as hypotension or fluid retention may increase with these medications. Safety during pregnancy has not been established, and use should be avoided. Breastfeeding should also be avoided if possible; if necessary, breastfeeding should be discontinued. There is limited experience with the use of this medication in children or neonates, so caution should be exercised. In case of overdose, intravenous normal saline may be used to support blood pressure maintenance and urination, while sympathomimetics that may put stress on the heart should be avoided. Professional treatment may be necessary as required.

Side effects

Hair growth, thickening, pigmentation increase, exudative rash, vesicular lesions, mucous membrane syndrome, thrombocytopenia, leukopenia, decreased hematocrit, decreased hemoglobin, decreased red blood cells, increased ALP, changes in T wave direction and amplitude on electrocardiogram, pericardial effusion, thrombosis, peripheral vascular edema, increased heart rate, elevated creatinine, elevated BUN, gastrointestinal disturbances, rash, mastalgia, gynecomastia, hemolytic anemia, pulmonary infiltrates, increased antinuclear antibodies, headache, intermittent claudication, frequent menstruation, nausea, vomiting

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture; therefore, it must be stored in a tightly sealed container. Also, it is important to maintain a storage temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the medication's effectiveness.

Appearance and packaging

Appearance

White round tablet

Package unit

30 tablets/bottle, 300 tablets/bottle, 500 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.